MarschnerK, KollmannK, SchweizerM, et al.A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism. Science2011;333(6038):87–90; doi: 10.1126/science.1205677
2.
CoutinhoMF, EncarnaçãoM, GomesR, et al.Origin and spread of a common deletion causing mucolipidosis type II: Insights from patterns of haplotypic diversity. Clin Genet2011;80(3):273–280; doi: 10.1111/j.1399-0004.2010.01539.x
3.
LiH, LeeWS, FengX, et al.Structure of the human GlcNAc-1-phosphotransferase alphabeta subunits reveals regulatory mechanism for lysosomal enzyme glycan phosphorylation. Nat Struct Mol Biol2022;29(4):348–356; doi: 10.1038/s41594-022-00748-0
4.
MatosL, VilelaR, RochaM, et al.Development of an antisense oligonucleotide-mediated exon skipping therapeutic strategy for mucolipidosis II: Validation at RNA level. Hum Gene Ther2020;31(13–14):775–783; doi: 10.1089/hum.2020.034
5.
LiH, DorayB, JenningsBC, et al.Structure of a truncated human GlcNAc-1-phosphotransferase variant reveals the basis for its hyperactivity. J Biol Chem2024;300(9):107706; doi: 10.1016/j.jbc.2024.107706
6.
GonçalvesM, EncarnaçãoM, MoreiraL, et al.Relevance of functional studies for assessing an antisense oligonucleotide-mediated exon skipping therapeutic strategy for mucolipidosis type II. Orphanet J Rare Dis2026; doi: 10.1186/s13023-026-04430-2
7.
YangX, DorayB, HennD, et al.Molecular insights into the regulation of GNPTalphabeta by LYSET. Nat Commun2026;17(1):3776; doi: 10.1038/s41467-026-70402-6
8.
DorayB, HennD, YangX, et al.Protocol to measure endogenous GlcNAc-1-phosphotransferase activity in SK-MEL-30 cells. STAR Protoc2025;6(3):103935; doi: 10.1016/j.xpro.2025.103935
